Jifang Gong

7PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 05, 2026
Extracellular vesicle proteins monitor and interfere with CLDN18.2-targeted CAR-T cell and antibody therapies against gastrointestinal cancers.

|Jun 23, 2026
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

|May 11, 2026
The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial.

|Mar 04, 2026
Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Chang Liu, Jiarui Li, Dan Liu

|Nov 29, 2025
Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.

Jiarui Li, Lian Liu, Min Tao

|Jul 16, 2025
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial.

Jia Liu, Jianwei Yang, Yuping Sun

Pageof 2

Frequent Collaborators

6 joint publications

Lin Shen

5 joint publications

Changsong Qi

4 joint publications

Chang Liu

3 joint publications

Jiajia Yuan